- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
C
CRSP
Crispr Therapeut
41.36
0.08+0.19%After Hours: 41.36 0.00 0.00%19:49 06/13 EDT
OPEN/PREV CLOSE40.28/41.28
TODAY RANGE40.00-41.74
VOL2.02M
MARKET CAP3.57B
52 WEEK RANGE30.04-67.88
AVG VOL (3M)2.16M
% TURNOVER2.34%
TURNOVER--
P/E (TTM)-9.1590
% RANGE4.21%
EPS(TTM)-4.5158
P/E(FORWARD)-7.4657
P/B1.953
BVPS21.18
DIVIDEND--
P/S95.04
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.51B
SHARES OUTSTANDING86.36M
NEXT EARNINGS08/04-08/08
FREE FLOAT84.84M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·1d ago
Crispr Therapeutics: Betting On A One-Shot Future
Seeking Alpha·3d ago
Crispr Therapeutics: Early Stage Research Updates Show Promise
Seeking Alpha·4d ago
Crispr extends gains for the seventh consecutive trading day
NASDAQ·4d ago
Analysts Expect JHSC To Hit $45
TipRanks·5d ago
CRISPR Therapeutics AG Shareholders Approve Key Proposals
Benzinga·5d ago
Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It
TipRanks·06/07 14:01
Crispr Therapeutics AG: Stock Soars Amid Bullish Trends
TipRanks·06/05 17:25
Crispr Therapeutics call volume above normal and directionally bullish
TipRanks·06/05 16:55
Bernstein Reaffirms Their Hold Rating on Crispr Therapeutics AG (CRSP)
NASDAQ·06/05 15:07
CRSP July 25th Options Begin Trading
NASDAQ·06/04 14:58
BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy
TipRanks·06/03 21:55
Promising Growth and Diversification Drive Buy Rating for Crispr Therapeutics AG
Seeking Alpha·05/30 19:00
Catalyst Watch: Crypto buzz with the Circle IPO, Snowflake event and the May Jobs Report
Same Industry
Name/Symbol
Change%
Price